Abstract
Objectives: To investigate potential mechanisms mediating the neuroprotective effect of thymoquinone (TQ) on dopaminergic neurons.
Methods: This study was conducted in the Chemistry and Biochemistry Institute, University of Veterinary Medicine, Vienna, Austria between June and August 2013. Primary cultures were prepared from embryonic mouse mesencephala (OFI/SPF) at gestation day 14. Four sets of cultures were kept untreated, treated with TQ on the eighth day in vitro (DIV) for 4 days, treated with 1-methyl-4-phenylpyridinium (MPP+) on the tenth DIV for 48 hours and co-treated with thymoquinone and MPP+. On the twelfth DIV, cultures were subjected to immunohistochemistry against tyrosine hydroxylase and fluorescent staining using LysoTracker® Deep Red, 5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethyl benzimidazolylcarbocyanine (JC-1) and 4’,6-diamidino-2-phenylindole stains.
Results: The MPP+ decreased the number of dopaminergic neurons by 40%, and increased the release of lactate dehydrogenase (LDH) into the culture medium. The TQ significantly rescued dopaminergic neurons and decreased the release of LDH at the concentrations of 0.1 and 1 µM. The TQ significantly shifted the red fluorescent intensity of the LysoTracker® Deep Red, increased the mitochondrial membrane potential as it increased the red:green florescent ratio of JC-1, and decreased MPP+-induced apoptotic cell death.
Conclusion: The TQ protects dopaminergic neurons in primary mesencephalic culture by enhancing lysosomal degradation that clears damaged mitochondria and inhibits mitochondria-mediated apoptotic cell death.
Parkinson’s disease (PD) is a chronic neurodegenerative and disabling disease affecting more than 4 million people worldwide.1 The disease is characterized by progressive and extensive loss of dopaminergic neurons in the substantia nigra pars compacta and their terminal region in the striatum.2 This leads to the classical motor symptoms of PD, most notably tremors, rigidity, bradykinesia, and postural instability.3 So far, the currently available medications using levodopa or dopamine receptor agonists are successful in improving clinical symptoms, but cannot halt or reverse degeneration of dopaminergic neurons. Recently, great attention has been paid globally to medicinal plants that may be active as neuroprotectants, antioxidants, or antiapoptotics. For instance, Chong et al4 reported that Danshensu, a main hydrophilic component of the Chinese medicinal herb Radix Salviae Miltiorrhizae, protected 6-hydroxydopamine-damaged Pheochromocytoma (PC12) cells through activation of phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K)/Akt and heme oxygenase-1 signaling pathways. Qin et al5 found that compound danshen tablets significantly improved spatial cognition in D-galactose-treated rats by reduction of the β-amyloid precursor protein (beta-APP).
Thymoquinone (TQ) (2-isopropyl-5-methyl-1,2-benzoquinone) is the main pharmacologically active constituent of volatile black seed oil.6 Thymoquinone was reported to hold a potential for neuroprotection in different in vitro and in vivo neurodegenerative disease models. In this context, Khan et al7 reported that TQ protected PC12 cells against beta-amyloid-25-35-induced neurotoxicity. Kanter et al8 found that TQ caused morphologic improvement in frontal cortex neurodegeneration caused by chronic toluene exposure in rats. Relevant to PD, we showed previously that TQ protected dopaminergic neurons in primary mesencephalic cell culture stressed with 1-methyl-4-phenylpyridinium (MPP+) and rotenone.9 In the current study, we investigate the mechanisms that underlie neuroprotection of dopaminergic neurons by TQ in primary mesencephalic cell culture.
Methods
Preparation of primary mesencephalic cell culture
This in vitro study was conducted in the Chemistry and Biochemistry Institute, University of Veterinary Medicine, Vienna, Austria between June and August 2013 in accordance with the guidelines of the European Union Council (86/609/EU) for the use of laboratory animals. The work does not require approval from the ethics committee as it used mouse embryos under the fifteenth day of gestation. Primary mesencephalic cell cultures were prepared from C57/B16 embryos according to Radad et al.10 To summarize, embryonic mouse mesencephala were dissected on the fourteenth day of gestation and cut into small pieces in a drop of Dulbecco’s phosphate-buffered saline (DPBS) (Invitrogen, Darmstadt, Germany), 2 ml of 0.2% trypsin solution (Invitrogen, Darmstadt, Germany) and 2 ml of 0.02% DNase I solution (Roche, Berlin, Germany) were added and the tissue was subsequently incubated in a water bath at 37°C for 7 minutes (min). Then, 2 ml of trypsin inhibitor (0.125mg/ml) (Invitrogen, Darmstadt, Germany) were added, the tissue was centrifuged at 100g for 4 min and the supernatant was aspirated. The tissue pellet was triturated 2-3 times with a fire-polished Pasteur pipette, each time 0.02% DNase I (Invitrogen, Darmstadt, Germany) was included in the medium. Dissociated cells were plated at a density of 257,000 cells/cm2 in Dulbecco’s modified Eagle’s medium (DMEM) (Sigma Aldrich, Hamburg, Germany) supplemented with 4mM glutamine, 10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, 30 mM glucose, 100 IU/ml penicillin, 0.1 mg/ml streptomycin, and 10% heat-inactivated fetal calf serum (Sigma Aldrich, Hamburg, Germany). The medium was exchanged on the first day in vitro (DIV) and on the third DIV. On the fifth DIV, half of the medium was replaced by serum-free DMEM containing 0.02 ml B-27/ml (Invitrogen, Darmstadt, Germany) DMEM. Serum-free supplemented DMEM was used for feeding from the sixth DIV, and subsequently replaced every second day.
Study design and treatment of primary mesencephalic cell cultures
A stock solution of TQ (Sigma Aldrich, Hamburg, Germany) (10 mM) was prepared in dimethyl sulfoxide (DMSO). Final concentrations of TQ were prepared in DMEM. The DMSO concentration in the culture medium did not exceed 0.01%. Four sets of cultures were treated as follows: The first set of cultures was treated with DMSO and kept as untreated controls. The second set of cultures was treated with TQ (0.01, 0.1, 1, and 10 µM) on the eighth DIV for 4 consecutive days to investigate the effect of TQ on the survival of dopaminergic neurons. The third set of cultures was treated with 10 µM of MPP+ on the tenth DIV for 48 hours (h). The fourth set of cultures was concomitantly treated with TQ (0.01, 0.1, 1, and 10 µ), and 10 µM of MPP+ on the tenth DIV for 48 h.
Identification of tyrosine hydroxylase immunoreactive (THir) neurons
Dopaminergic neurons were identified immunocytochemically by staining tyrosine hydroxylase. Cultures were rinsed carefully with phosphate buffered saline (PBS, pH 7.2) at the end of each treatment and fixed in 4% paraformaldehyde for 45 min at 4°C. After washing with PBS, cells were permeabilized with 0.4% Triton X-100 for 30 min at room temperature. Cultures were washed 3 times with PBS and incubated with 5% horse serum (Vectastain ABC Elite kit, Biozol Diagnostica Vertrieb GmbH, Eching, Germany) for 90 min to block nonspecific binding sites. To determine the number of THir in cultures, cells were sequentially incubated with anti-TH primary antibody overnight at 4°C, biotinylated secondary antibody (Vectastain), and avidin-biotin-horseradish peroxidase complex (Vectastain) for 90 min at room temperature and washed with PBS between stages. The reaction product was developed in a solution of diaminobenzidine (1.4 mM) in PBS containing 3.3 mM hydrogen peroxide and stained cells were counted with a Nikon inverted microscope in 10 randomly selected fields per well at 10x magnification.
Measurement of lactate dehydrogenase activity
Cellular injury was quantitatively assessed by measuring the activity of lactate dehydrogenase (LDH) released from damaged cells into the culture medium. The reaction was initiated by mixing 0.2 ml of cell-free supernatant (diluted 1:1 with aqua dest.) with potassium phosphate buffer containing ß-nicotinamide adenine dinucleotide (NADH) and sodium pyruvate (0.18 and 0.62 mM in potassium phosphate buffer) in a final volume of 0.5 ml in 1 ml cuvettes. The decrease of NADH was spectrophotometrically (NOVASPEC II, GE Healthcare Europe GmbH, Freiburg, Germany) monitored. Reagent blanks were subtracted. The LDH activity was calculated from the slope of the decrease in optical density at 334 nm over a 3 min-time period. The LDH release is proportional to the number of damaged or destroyed cells.11,12
Fluorescence staining
LysoTracker® Deep Red (Life Technologies™, Invitrogen, Grand Island, NY, USA) is a red fluorescence dye used for labeling acidic organelles in live cells including autophagolysosomes. Cultures were treated with 1 µM of TQ (a concentration that significantly protected dopaminergic neurons in MPP+-treated cultures) on the eighth DIV and co-administered with MPP+ (10 µM) on the tenth DIV for 2 days. On the twelfth DIV, culture medium was aspirated and cultured cells were incubated with a new medium containing 100 nM LysoTracker® Deep Red fluorescence dye (Life Technologies™, Invitrogen, Grand Island, NY, USA) for 15-30 min at 37°C. After washing with DPBS, cultured cells were photographed on a Nikon inverted microscope equipped with epifluorescence attachment using a rhodamine filter set (580/590, G-2A) and a Coolpix 990 digital camera (Nikon, Otawara, Japan). Three photos were taken randomly from each well. All photos were analyzed densitometrically by Adobe Photoshop® software.
5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolyl-carbocyanine (JC-1) is a lipophilic cationic dye that selectively enters into mitochondria. In healthy cells with high mitochondrial membrane potential (Δψm), JC-1 spontaneously forms complexes known as J-aggregates with intense red fluorescence. The dye remains in the monomeric from with green fluorescence in case of apoptotic or damaged cells. The JC-1 red:green ratio is used to estimate changes in Δψm.13 The JC-1 was dissolved in DMSO and further diluted in DMEM (10 µg/ml final concentration). After removal of the culture medium, cells were loaded with JC-1 for 15 min at 37°C, rinsed twice with PBS, and photographed on a Nikon inverted microscope equipped with epifluorescence attachment using a rhodamine filter set (520 DM/520 BA, B-2A) and a Coolpix 990 digital camera (Nikon, Otawara, Japan). Three photos were taken randomly from each well. Fluorescence intensity of the red:green ratio was determined semi quantitively by using Adobe Photoshop® software.
4’,6-diamidino-2-phenylindole (DAPI) is a fluorescent stain that binds strongly to DNA. It passes through intact membranes of both live and fixed cells. Cells were fixed with 4% paraformaldehyde for 45 min at 4°C. After washing with PBS (pH 7.2), cells were permeabilized with 0.4% Triton X-100 for 30 min at room temperature. The DAPI solution (2 µM final concentration) was added to the cultures at room temperature for 5 min in the dark. After washing with DPBS, 3 photos were taken randomly from each well with a Coolpix 990 digital camera connected to an inverted microscope with epifluorescence attachment using an ultraviolet filter (Nikon, Otawara, Japan). Nuclei with condensed and fragmented chromatin were counted when the photos were analyzed with Adobe Photoshop® software.
Data was obtained from 12 wells (from 2 repeats) for each treatment condition. Data were expressed as mean ± SEM. Comparisons were made using ANOVA and post-hoc Duncan’s test using the Statistical Analysis System program 1998 (SAS Institute Inc., Cary, NC, USA). P<0.05 was considered as statistically significant.
Results
Effect of TQ on the survival of dopaminergic neurons
Treatment of cultures with TQ (0.01, 0.1, 1, and 10 µM) on the eighth DIV for 4 consecutive days produced no significant effects on either the survival rate or the morphology of THir neurons (data not shown). Treatment of cultures with MPP+ (10 µM on the eighth DIV for 48 h) decreased the number of dopaminergic neurons by around 40% compared with untreated control cultures (Figure 1A). Surviving neurons after MPP+ treatment showed fewer, shortened, and thickened neurites (Figure 1B). Co-treatment of cultures with TQ (on the eighth DIV for 4 days) and MPP+ (10 µM on the tenth DIV for 48 h) prevented dopaminergic cell loss by around 25% at 0.1 and 1 µM (Figure 1A), and improved the morphology of surviving neurons compared to MPP+-treated cultures (Figure 1B).
The TQ attenuated MPP+-induced LDH increase in primary mesencephalic cell culture. The MPP+ (10 µM from the tenth to twelfth DIV) increased LDH release in the culture medium by 145% compared with untreated cultures (Figure 2). The TQ significantly decreased LDH release in the culture medium by around 70% at 0.1 and 0.1 µM concentrations compared with MPP+-treated cultures (Figure 2).
The TQ increased LysoTracker® Deep Red fluorescence and the red:green fluorescence ratio of JC-1, and decreased MPP+-induced apoptotic cell death in primary mesencephalic cell culture. LysoTracker® Deep Red fluorescent intensity increased 3 folds (682%) in the cultures co-treated with TQ and MPP+ compared with the cultures treated with MPP+ alone (222%) (Figure 3A). In parallel, cultures co-treated with MPP+ and TQ showed higher red fluorescence than the cultures treated with MPP+ alone (Figure 3B).
Treatment of cultures with MPP+ (10 µM on the tenth DIV for 48 h) caused dissipation of Δψm. Cultures treated with MPP+ showed a significant decrease in red:green fluorescence ratio of JC-1 by around 17% compared with untreated controls (Figure 4A). However, co-treatment of MPP+-treated cultures with 1 µM TQ from the eighth-twelfth DIV significantly increased Δψm as it increased the red:green fluorescence ratio of JC-1 by around 24% compared with MPP+-treated cultures (Figure 4A). As shown in Figure 4B, MPP+-treated cultures co-administered with TQ displayed much higher red fluorescence than the cultures treated with MPP+ alone.
Staining of cultured cells with the nuclear fluorescence dye, DAPI revealed that MPP+ (10 µM on the tenth DIV for 48 h) increased the number of nuclei showing apoptotic features by 139% compared with untreated cultures (Figure 5A). Against MPP+, TQ was shown to decrease the number of apoptotic nuclei by around 100% compared with MPP+-treated cultures (Figure 5A). Apoptotic nuclei appeared with highly condensed and fragmented chromatin (Figure 5B). Please refer to Table 1 for a summary of the study findings.
Discussion
In the present study, TQ was investigated to ascertain whether it protected mesencephalic dopaminergic neurons against MPP+-induced cell death through activation of enzymatic degradation, preservation of mitochondrial function, and inhibition of apoptotic cell death. Clearly, MPP+ was found to significantly decrease the survival of dopaminergic neurons and increase the release of LDH into the culture medium. The MPP+ toxicity involves its selective uptake by dopaminergic neurons through the dopamine transporter and inhibition of mitochondrial complex I activity with subsequent mitochondrial depolarization.14 In parallel, the use of JC-1 fluorescence dye in our current study showed that MPP+ significantly decreased the Δψm of cultured cells as indicated by the decreasing red:green fluorescence ratio of JC-1. Similar MPP+-induced reduction of Δψm was reported in other in vitro disease models.15,16 Mitochondrial damage has long been implicated in the death of nigrostriatal dopaminergic neurons in both PD patients and experimental models.17,18 Staining of primary dopaminergic cultures with blue-fluorescent DAPI nucleic acid stain showed that a significant number of the cells displayed features of apoptosis, most notably chromatin condensation, and fragmentation. Previously, Tang et al19 and Xu et al16 demonstrated that MPP+ caused apoptotic cell death in PC12 and SH-SY5Y cells. The MPP+-induced apoptosis was reported to occur as the result of disruption of mitochondrial transmembrane potential and opening of the permeability transition pore.20
Similar to our previous report,9 co-treatment of primary mesencephalic cell cultures with TQ and MPP+ was found to protect dopaminergic neurons and decreased the release of LDH into the culture medium. Since that time, no evidence in the literature has shown how TQ protected dopaminergic neurons in the primary mesencephalic cell culture. Staining of cultures with LysoTracker® Deep Red showed that TQ significantly increased the red fluorescence of the dye compared with MPP+-treated cultures, indicating enhancement of the formation of many autophagolysosomes, the sites of lysosomal degradation, by TQ. This is supported by the findings of He and Klionsky21 who correlated the fluorescent signals of LysoTracker® Deep Red to the upregulation of autophagy in zebrafish. Increased red fluorescence of LysoTracker® Deep Red is attributed to the formation of many autophagosomes and autophagolysosomes that retain much dye as the result of increasing their acidification. Using JC-1 fluorescent dye showed that TQ significantly enhanced Δψm as it increased the red:green fluorescence ratio of JC-1 compared with MPP+-treated cultures. The TQ was similarly found to protect rat cortical neurons against ethanol- and Aß1-42-induced neurotoxicity through inhibition of mitochondrial membrane depolarization.22,23 Counting of apoptotic nuclei using blue-fluorescent DAPI nucleic acid stain indicated that TQ decreased MPP+-induced apoptotic cell death in primary mesencephalic cell cultures. In accordance, Ullah et al22 reported that TQ inhibited apoptotic cell death in ethanol-treated rat cortical neurons and attributed this effect of TQ to the preservation of mitochondrial integrity. Zhang et al24 reported that mitochondrial clearance protected cultured cortical neurons against ischemia-reperfusion-induced cell damage.
In conclusion, correlating such results would therefore suggest that TQ might activate a lysosomal degradative process in dopaminergic neurons, where clearance of damaged mitochondria results in reduced mitochondria-mediated apoptotic cell death. This might raise the possibility of using TQ as a potentially therapeutic intervention in PD patients. Further molecular studies are required for better understanding the underlying mechanism of TQ.
- Received April 29, 2014.
- Accepted November 3, 2014.
- Copyright: © Neurosciences
Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.